Ocumension Therapeutics HK$793.8 million top-up placement of shares
We advised the placing agent in connection with the equity offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
RemeGen HK$4 billion Hong Kong IPO
Davis Polk advised the underwriters in the initial public offering of RemeGen Co., Ltd. on the Hong Kong Stock Exchange and an international offering and listing in reliance on Rule 144A…
JW (Cayman) Therapeutics HK$2.33 billion Hong Kong IPO
Davis Polk advised the underwriters in the initial public offering of JW (Cayman) Therapeutics Co. Ltd on the Hong Kong Stock Exchange and an international offering and listing in reliance…
Ocumension Therapeutics HK$1.55 billion IPO and HKEX listing
Davis Polk advised the underwriters in the initial public offering of Ocumension Therapeutics on the Hong Kong Stock Exchange and an international offering and listing in reliance on Rule…
Shenzhen Hepalink Pharmaceutical Group HK$4.05 billion IPO
Davis Polk advised Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering…
NetEase HK$20.9 billion secondary listing and IPO on HKEX
Davis Polk advised the underwriters in the secondary listing and initial public offering of NetEase, Inc. on the Hong Kong Stock Exchange. The gross proceeds from the global offering…
Legend Biotech $487 million IPO
Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend Biotech Corporation of 21,188,750 American Depositary Shares, each…
Davis Polk Advises Haitong UniTrust International Leasing Co., Ltd. on Its HK$2.32 Billion (US$297.74 Million) Initial Public Offering
Davis Polk advised Haitong UniTrust International Leasing Co., Ltd. in connection with its spinoff from Haitong Securities Co., Ltd. (dual listed on the Hong Kong Stock Exchange and the…
Meituan Dianping HK$33.14 Billion (US$4.22 Billion) Initial Public Offering
Davis Polk advised the underwriters as joint global coordinators in the Hong Kong initial public offering of Meituan Dianping. The gross proceeds from the offering amounted to approximately…
Ping An Healthcare and Technology Company Limited HK$8.77 Billion ($1.12 Billion) Initial Public Offering
Davis Polk advised the joint global coordinators in the Hong Kong initial public offering of Ping An Healthcare and Technology Company Limited. The gross proceeds from the offering…